We are international
Donate
TEXT SIZE   


VELCADE® (bortezomib) for Injection
Information on VELCADE® for health professionals.
06.23.04

VELCADE® (bortezomib) for Injection is an antineoplastic agent available for intravenous injection (IV) use only. It has been approved by the FDA for the treatment of myeloma.

Questions and answers about VELCADE® (bortezomib) for Injection for healthcare professionals.
Click here to view the brochure for health care professions.


Mechanism of Action Video
Illustrates how VELCADE® (bortezomib) forInjection works. Click here to view.

Press Releases:

VELCADE� Patient Information Materials

VELCADE� Clinical Trials

Millennium's Web Site


 related articles